Steroid Synthesis Inhibitors
"Steroid Synthesis Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that bind to and inhibit enzymes involved in the synthesis of STEROIDS.
Descriptor ID |
D065088
|
MeSH Number(s) |
D27.505.519.389.870 D27.505.696.399.450.855
|
Concept/Terms |
Steroid Synthesis Inhibitors- Steroid Synthesis Inhibitors
- Inhibitors, Steroid Synthesis
- Synthesis Inhibitors, Steroid
- Steroid Synthesis Blockers
- Blockers, Steroid Synthesis
- Synthesis Blockers, Steroid
- Steroid Synthesis Antagonists
- Antagonists, Steroid Synthesis
- Synthesis Antagonists, Steroid
|
Below are MeSH descriptors whose meaning is more general than "Steroid Synthesis Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Steroid Synthesis Inhibitors".
This graph shows the total number of publications written about "Steroid Synthesis Inhibitors" by people in this website by year, and whether "Steroid Synthesis Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2015 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Steroid Synthesis Inhibitors" by people in Profiles.
-
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study. Lancet Oncol. 2021 11; 22(11):1541-1559.
-
Impact of bone-targeted therapies in chemotherapy-na?ve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302. Eur Urol. 2015 Oct; 68(4):570-7.